5-Bromo-1-methyl-1H-pyrazol-3-amine, 95.0%, 250mg

4-Morpholin-4-yl-2-nitrobenzoic acid, 95.0%, 25g

2-(2-Fluoro-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

3,5-Dinitro-4-methylbenzoic acid, 97.0%, 500g

3-(1-Methyl-1h-benzo[d]imidazol-2-yl)propanoic acid, 98%, 500mg

5-Methylsulfonyl-2-[((R)-2,2,2-trifluoro-1-methylethyl)oxy]benzoic acid methyl ester, 97%, 50mg

4-Amino-5-bromo-2-methylpyridine, 95.0%, 5g

1-(2,2,2-Trifluoroacetamido)cyclohexane-1-carboxylic acid, 98%, 10g

1H-INDAZOLE, 3-BROMO-5-IODO-, 95%, 5g

3-(5-BROMO-2-FLUORO-4-METHOXY-PHENYL)-PROPIONIC ACID, 95.0%, 1g

(S)-2-Amino-3-chloropropanoic acid hydrochloride, 95.0%, 10g

Acide 1-naphtylacétique, min 99 %, pa, 25 g, emballage plastique.

(S)-N-(Piperidin-3-yl)cyclopropanecarboxamide hydrochloride, 1g